2m 2m 2m 2m 2m 2m 2m
TURN THERAPEUTIC (TTRX)
NASDAQ
$9.53-$0.61 (-5.97%)
Price as of Nov 13, 2026 2:10 PM EST- $307.6MMarket Cap
- 147.68%1-Year Change
- BiotechnologyIndustry
TURN THERAPEUTIC (TTRX)
$9.53-$0.61 (-5.97%)
TTRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.13 | ||
Change | -$0.44 (-4.16%) | ||
Open | $10.20 | ||
High | $10.50 | ||
Low | $9.99 | ||
Previous Close | $10.57 | ||
Volume | 98,816 | ||
30-Day Average Volume | 94,576 | ||
1-Week Change | 13.31% | ||
1-Month Change | -8.82% | ||
1-Year Change | 147.68% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 30.4M | ||
Total Assets | $16.3M | ||
Market Cap | $307.6M | ||
Enterprise Value | $303.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$1.5M | ||
EBIT | $0.00 | ||
EBITDA | $14,681.00 | ||
Net Working Capital | $7.6M | ||
EPS | -$0.21 | ||
Enterprise Value/EBITDA | 20,669 | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | -48 | ||
PEG | 10 | ||
Price/Free Cash Flow | -199 | ||
Price/Operating Cash Flow | -199 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue